Showing 2391-2400 of 5661 results for "".
Are We What We Eat?
https://practicaldermatology.com/columns/clinical-focus-1/are-we-what-we-eat/23507/Understanding adverse food reactions and their role in atopic dermatitis.AAD Survey: One-Third of Americans Flunk Basic Quiz on Skin Cancer and Sun Exposure
https://practicaldermatology.com/topics/skin-cancer-photoprotection/aad-survey-one-third-of-americans-flunk-basic-quiz-on-skin-cancer-and-sun-exposure-1/23495/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-3/23049/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20730/'Clean Beauty' in Dermatology: A Scoping Review
https://practicaldermatology.com/issues/july-2025/clean-beauty/36492/The emergence of “clean beauty” as a consumer label has become a notable marketing trend, developed in the absence of standardized regulatory definitions, and it has been associated with shifts in consumer behaviors on a global scale.The Dermatology Therapeutic Landscape: New and Emerging Options
https://practicaldermatology.com/topics/psoriasis/the-dermatology-therapeutic-landscape-new-and-emerging-options/23662/From new developments in psoriasis to atopic dermatitis and beyond, dermatology anticipates a number of emerging treatments.Cutaneous T-Cell Lymphoma: Mogamulizumab as a Novel Treatment for Refractory Mycosis Fungoides and Sezary Syndrome
https://practicaldermatology.com/youngmd-connect/resident-resource-center/Cutaneous-T-Cell-Lymphoma-Mogamulizumab-as-a-Novel-Treatment-for-Refractory-Mycosis-Fungoides-and-Sezary-Syndrome/23409/An overview of the diagnosis and prognosis of CTCL.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20594/Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20748/The HRQoL Impact of Psoriasis: Perspectives for Value-Based Reimbursement
https://practicaldermatology.com/topics/psoriasis/the-hrqol-impact-of-psoriasis-perspectives-for-value-based-reimbursement/20932/Understanding the psychological/social burden of psoriasis on patients is critical as new therapeutics position themselves for reimbursement in a crowded and increasingly undifferentiated field.